InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: Cynmark24 post# 184446

Saturday, 09/18/2021 1:55:42 PM

Saturday, September 18, 2021 1:55:42 PM

Post# of 232251
The development of Leronlimab has been actually very good, faster and less expensive than most. It is on the cusp of being proved in more indications. Already the HIV indication was proved in Phase 3. Just needs the final BLA piece of the puzzle. The Covid indication could quite quickly result in billions in revenue. That will be the time to transfer the CEO role to someone good at directing a Revenue Generating Biotech. Nader will be a multi billionaire and will do what is best for CytoDyn and his fellow shareholders. For now we need a CEO who is good at raising funds pre Revenue. That man is Nader one of the best in the world who has grown CytoDyn into the one of largest by market cap pre revenue biotech on the OTC.
Those that can not see the value in CYDY might be inexperience biotech investors or simply disingenuous short sellers.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News